About Us
We believe in people and their potential. We envision a world where everyone is operating at peak mental performance, free from the stresses and imbalances that hold us back.
MISSION
Empowering human potential.
Using evidence-informed research, we are on a mission to unlock human performance and empower people to achieve their full potential. Through end to end research, extraction, formulation and delivery, we aspire to define and standardize the future of modern medicine.
OUR STORY
HAVN Life is a part of a global community taking an active part in supporting research addressing mental health disorders. Working with Veterans and thought leaders in the military, HAVN Life is developing innovative formulations to support clinical trials addressing PTSD recovery and other trauma related disorders.
We are focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing innovative mental health treatment to support brain health and enhance the capabilities of the mind.
With an extensive team of industry leaders with 20+ years of experience in this space, HAVN Life is formulating the next generation of medicine using psychedelic compounds.
Our Values
At HAVN Life, we are dedicated to innovation, diversity and implementing the highest standards of the scientific method.
We have a deep-seated drive to help others and share our knowledge. With a range of standardized, quality-controlled formulated products, HAVN Life will provide cutting edge technology and intellectual property for mental health and human performance with a strong focus on psychoactive natural healthcare products.
Our Team
Collaboration across disciplines
Creating positive patient experiences and mental health outcomes
Tim Moore
CEO and Chair
Former CEO of Green Growth Brands. Led the Company to ~$1 Billion market cap. Former President of Clorox Canada and COO of Synnex Canada.. Managing Director at Brita North America group, responsible for building a new business organization across B2B and B2C divisions.
Dr. Ivan Casselman
Director
Executive-level cannabis advisory. Formerly on the management team of NextLeaf during IPO Extensive nutraceutical formulation, with products available in legal cannabis markets in North America. Research spanning human use of psychedelics (ethnobotany and ethnopharmacy) to the study of plant genetics and analytical chemistry.
Alexzander Samuelsson
Director
Lead chemist of a publicly traded extraction company. Developed intellectual property and patented methods in the extraction of cannabis oils. Strategic support for startups in their implementation of capital projects in Canada, Europe, Central and South Asia through his consulting company Development Catalyst.
Jenna Pozar
Chief Operations Officer
18 years of NHP marketing and logistics experience, including Jamieson Wellness and Body Plus. Responsible for the growth and planning for 200+ retail store accounts and three national chains, with a portfolio of eight natural health and performance brands.
Path To Market
regulated Route To Market
. . . . .
.
.
.
.
.
Direct To Consumers
Natural Health Products
. . . . .
.
.
.
.
.
Contract Manufacturer
(White Label)
Natural Health Products
.
.
.
.
.
Direct To Consumers
Contract Manufacturer
(White Label)
ReSTRICTED COMPOUND Route To Market
. . . . .
.
.
.
.
.
Supply Academic Research
(Dealers License)
Psychedelic Extraction and Supply
. . . . .
.
.
.
.
.
Formulate Microdosing Therapies
(Pre-Clinical Trials)
Psychedelic Extraction and Supply
.
.
.
.
.
Supply Academic Research
(Dealers License)
Formulate Microdosing Therapies
(Pre-Clinical Trials)
Mushroom Market
Demand for mushrooms is growing. The market for mushrooms such as Lion’s Mane, Cordyceps, Reishi, and Chaga is rising. These mushrooms have numerous benefits that we are still discovering today. Mushrooms are an extremely beneficial and nutritious functional food that will continue to be a key player in the global functional food market. The market is set to reach a value of $34.3 Billion USD by 2024.
Growing Mushroom Market
Global Revenue in 2016 – 2024
The global functional food market is expected to reach $34.3 Billion USD by 2024, registering a CAGR of 8.04% during the forecast period (2019-2024)
The market studied is expected to experience huge demand for Reishi and Cordyceps and this is why HAVN Life has decided to pursue formulations with these mushrooms.
Roadmap
2020
HAVN Labs
One of the first companies to receive permission from Health Canada to work with psilocybin
2020
HAVN Labs
Finalize Pre-Clinical Protocols for Compound Extraction and Supply
2021
HAVN Retail
Manufacture & Distribute at Scale
2021
HAVN Labs
Licensed Dealer Approval
2021
HAVN Labs
Supply Clinical Trials with GMP Certified Psychedelic Compounds
2021
HAVN Labs
Formulate Psychedelic Therapies for Clinical Trials
2022+
HAVN Retail
Expansion of Distribution Channels
2022+
HAVN Labs
Publish Analytical Method Results